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Abstract 
 
Metabolic oligosaccharide engineering (MOE) permits the introduction of subtle 
modifications into monosaccharides residues within cellular glycans. The first 
landmark in the development of this technique started in its application for the study 
of sialic acid biology. This sugar has a rather privileged role in vertebrate biology as it 
is often at the capping position of cell surface glycans and is therefore exposed for 
interactions with exogenous cells and proteins. MOE has now been applied to a myriad 
of problems in glycobiology, namely to disrupt glycan biosynthesis, chemically modify 
cell surfaces, probe metabolic flux inside cells and for proteomics analysis of cells. 
 
In this work the synthesis of three non-natural ManNAc analogues, ManNAz, 
ManNLev and ManNSH is described. It is also reported the enzymatic conversion of 
these ManNAc analogues into the respective sialic acid derivatives by the sialic acid 
aldolase. The enzymatic reaction rates obtained with ManNAz, ManNLev and ManNSH 
were 0.00130, 0.00080 and 0.00075 µmol/min, respectively. Amongst all the ManNAc 
analogues, ManNAz was found as the best candidate for MOE. The results obtained, 
which are on the same scale (0.0027µmol/min) as those obtained for the natural 
substrate (ManNAc) of the enzyme, are very positive. 
 
It is also described the peracetylation of the ManNAc analogues, for further 
manipulation. Ac4ManNAz was further used to perform several reactions with the 
purpose of labelling this compound with fluorine. In the future, other strategies will be 
applied to the other peracetylated derivatives (Ac4ManNLev and Ac4ManSAc), namely 
fluorescent labelling. 
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Resumo 
 
A engenharia metabólica de oligossacáridos (MOE) permite a modificação subtil 
dos resíduos de monossacáridos que constituem as glicanas presentes na membrana 
celular. A primeira referência no desenvolvimento desta técnica começou com a sua 
aplicação no estudo da biologia do ácido siálico. Este açúcar representa um 
importante papel na biologia dos vertebrados, uma vez que se encontra na posição 
terminal das glicanas da superfície da célula, estando exposto a interacções com 
células e proteínas exógenas. Actualmente, MOE é aplicado a diferentes problemas da 
glicobiologia, tal como bloquear a biossíntese de glicanas, modificar quimicamente a 
superfície das células, servir de sonda para o fluxo metabólico no interior da célula e 
fazer a análise proteómica de células.  
 
Uma série de três análogos de ManNAc (ManNaz, ManNLev e ManNSH) foram 
sintetizados e utilizados na reacção com a enzima ácido siálico aldolase, a fim de 
saber qual é o melhor candidato para ser aplicado em MOE. A velocidade de reacção 
obtida para estes análogos de ManNAc foram 0,00130, 0,00080 e 0,00075 mol/min 
para ManNAz, ManNLev e ManNSH, respectivamente, revelando que o melhor 
candidato para usar em MOE é ManNAz. Além disso, os resultados obtidos são muito 
positivos, uma vez que são da mesma ordem de grandeza (0,0027µmol/min) que o 
obtido para o substrato natural da enzima (ManNAc). 
 
Os três análogos de ManNAc foram acetilados, e utilizou-se o derivado 
Ac4ManNAz para realizar várias reacções com o propósito de derivatizar este 
composto com flúor. No futuro, outras estratégias serão aplicadas aos outros 
derivados peracetilados (Ac4ManNLev e Ac4ManSAc), nomeadamente a derivatização 
com uma sonda fluorescente. 
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1. Introduction 
 
1.1. General 
 
The carbohydrates are the most abundant organic molecules found in nature 
and they are of an extreme importance in our world. For example, the two most 
abundant carbohydrates are cellulose (figure 1.1), which is found in the plant walls, 
and chitosan that constitutes the shell of marine organisms. The carbohydrates are 
also found in animals but in a smaller amount and their size are also smaller, normally 
occurring as oligosaccharide structures of only 20 residues or less. 
 
 
Figure 1.1 – Up: Chemical structure of chitosan; Down: Chemical structure of cellulose. 
 
Comparing to the other major class of biomacromolecules, namely nucleic 
acids, proteins and lipids, and relatively to the biological functions, mammalian 
oligosaccharides are of an extreme importance since they can be highly branched 
molecules and their monomeric units may be connected to one another by many 
different linkage types1.  
The carbohydrates can be present without being attached to other molecules, 
but in mammalian species they are normally attached to proteins and lipids and are 
generically referred to as “glycoconjugates” or “glycans”2. When present on the cell 
surface, this type of conjugates largely determines the interactions of the host cell 
with other cells or with its environment. Moreover, several biological recognition 
processes, such viral and bacterial infections, cancer metastasis, inflammatory 
response, innate and adaptive immunity, and many other receptor-mediated 
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signalling processes are modulated by protein-carbohydrate or carbohydrate-
carbohydrate interactions (figure 1.2)3.  
 
 
Figure 1.2 – Interactions of carbohydrates in the cell surface. 
 
In addition to serving as a surface “sugar code” that identifies a cell to the 
outside world, oligosaccharides can also modify the intrinsic properties of the specific 
proteins and lipids to which they are conjugated4. For example, for proteins, these 
properties include catalytic activity, resistance to proteolytic attack, solubility and 
conformational aspects including folding5.  
The knowledge of the influence of oligosaccharides in different biological 
processes is growing very fast. For this reason, there is an intense interest in 
modulating cell-surface glycans for different purposes ranging from study of 
engineering cell function to treatment of diseases. 
Structure-function correlation is a difficult task because glycan chains of 
glycoproteins are complex, flexible, and microheterogenous in nature, which makes 
simple structural characterization highly challenging. On the other hand, with the 
advent of sophisticated analytical, spectral, and biological techniques, the ‘glycomics’ 
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analyses of cellular glycans is becoming possible6. However, even when 
glycoconjugate structures are identified, in situ regulation of glycan production 
remains difficult with few methods available to precisely up- or down-regulate the 
biosynthesis of a targeted oligosaccharide structure. Nowadays, the availability of 
sophisticated chemical or enzymatic methods for the synthesis of glycoconjugates of 
biological interest has allowed the production of glycans outside a cell. However, less 
extended glycans can be added exogenously to the cell to reproduce the effects seen 
upon endogenous production (e.g. the exception is glycosphingolipids, which can be 
synthesized and added exogenously). 
Taking into consideration the immense challenges that glycobiologists have 
encountered to manipulate glycans in living cells, a new technology has been 
developed over the past decade by the chemical biology community. This new 
technology is now generally referred to as “metabolic oligosaccharide engineering” 
(MOE) and offers major advances in glycobiology. MOE technology was largely 
pioneered by Reutter and colleagues for sialic acid and is now proving to be 
remarkably versatile, having now been demonstrated for several different 
monosaccharides7. 
 
 
 
1.2. Metabolic Oligosaccharide Engineering 
 
 
 
1.2.1. MOE—the Incorporation of Non-Natural Monosaccharides into Glycans 
 
Metabolic oligosaccharide engineering is the process of modulating cellular 
glycan structures by biosynthetic introduction of unnatural sugars containing unique 
functional groups termed "bioorthogonal chemical reporters", as shown in figure 1.3. 
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Figure 1.3 – Metabolic Oligosaccharide engineering. 
 
By the previous figure (figure 1.3), it is possible to understand how this 
technique works. First, an unnatural metabolic precursor is taken up by the cell and 
suffers several enzymatic reactions in the cytosol. Then the unnatural metabolic 
precursor is incorporated in an intracellular glycoprotein in golgi apparatus, that will 
be exposed in the cellular membrane bearing the modified glycan. 
This basic technology has proven to be remarkably broad-based, with metabolic 
incorporation of non-natural sugar residues already demonstrated for several of the 
major classes of mammalian carbohydrates. These include N-linked glycoproteins8, 
mucins9 (O-linked glycoproteins), glycosphingolipids10, glycosoaminoglycans (GAGs)11, 
and O-GlcNAc-modified nuclear and cytosolic proteins12. 
 
Figure 1.4 – Structures of the most common monosaccharides on mammals and their 
predominant glycan distribution (in colours). 
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In addition to the well-studied mammalian systems, pilot studies have shown 
incorporation of carbohydrate analogues into bacterial lipooligosaccharides13 and cell 
wall components14. 
 
 
1.2.2. Glycosylation — a Catalogue of ‘Building Blocks’ and Biosynthetic 
Elements 
 
In spite of the complexity of glycan production, the biosynthetic components 
that comprise the ‘glycosylation machinery’ have become well defined and the 
resulting knowledge is critical for the continuous progress in MOE.  
To use MOE’s technology is extremely necessary to possess information on the 
genes responsible for the metabolic processing of the nine common monosaccharides 
found in mammalian oligosaccharides (Glc, Gal, Man, Xyl, GlcNAc, GalNAc, GlcN, Fuc 
and sialic acid, 1–9 figure 1.4). These monosaccharides are converted to nucleotide 
sugar ‘building blocks’ and assembled into glycoconjugates by the sequential and 
concerted actions of cytosolic processing enzymes, membrane transporters, 
glycosyltransferases, and glycosidases.  
Besides, it is very important to have a detailed knowledge of the sequential 
metabolic intermediates found along the biosynthetic pathways responsible for glycan 
production, since this is a critical point to ensure that the intended pathway is 
successfully targeted. From a historical perspective, in many cases the 
characterization of pathway metabolites significantly predated recently obtained 
genomic information on the proteins responsible for enzyme and transporter activities. 
Much of the biochemistry of the sialic acid pathway, for example, was determined in 
the 1960s by Roseman and colleagues15. 
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1.2.3. Overcoming the Plasma Membrane Barrier to Analogue Up-Take by 
Cells 
 
1.2.3.1. Non-Natural Sugars Are not Membrane Permeable 
 
One of the most common problems associated with MOE experiments is the 
initial uptake of the sugar analogues by a cell. Although families of transporter exist 
for common dietary sugars such as glucose, they are usually refractory to modified 
derivatives such as the GlcNAc analogues now used in MOE16. 
An analogous uptake problem exists for ManNAc as no membrane transporters 
have been reported for even the natural form of this sugar, which represents a 
significant obstacle to sialic acid pathway intervention. Therefore, millimolar quantities 
of mannosamine analogues are required to maximize metabolic incorporation into 
sialic acids17. 
Beyond that, non-receptor mediated uptake of carbohydrates into a cell by 
diffusion is severely hampered by the polarity of sugars and experimental evidence 
suggests that the number of hydroxyl groups in the glycan determines the rate and 
extent of uptake. For example one additional hydroxyl group can create an obstacle to 
uptake and the multiple hydroxyl groups of a disaccharide constitute an even larger 
energy barrier to membrane diffusion.  
One strategy for improving the cellular uptake of monosaccharides has been to 
increase the hydrophobicity of the sugar by appending lipophilic groups due to a 
strong correlation that exists between membrane permeability and partitioning of 
solutes into an organic solvent.  
Theoretically, an additional increase in the size and hydrophobicity of the 
aglycon moiety should improve uptake but in practice strongly amphipathic 
compounds act like detergents. Thus, for example pyrene derivatives of glycosides or 
sugars containing alkyl chains of 15 carbons result in cell lysis. 
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1.2.3.2. Short Chain Fatty Acids Increase Cellular Uptake and Modulate 
Biological Function 
 
To prevent some problems encountered when attaching a single, highly 
lipophilic moiety to transport a sugar across a cellular membrane, modified analogues 
containing short chain fatty acids (SCFAs) were developed to increase cellular uptake. 
SCFAs represent a compromise between extremely lipophilic groups that damage the 
membrane and hydrophilic nature of the sugar that prevents membrane uptake. 
Normally SCFAs, that are usually acetates, are used to improve bioavailability of drugs 
(e. g., acetylsalicylic acid), second messengers (e. g., dibutyryl cAMP), and 
glycosidase inhibitors (e. g., carbonoyloxy analogue of swainsonine)18. This is due to 
the number of esterases present in cells and some of them have broad substrate 
specificity, therefore it is possible to remove the acetates and convert the pro-drugs 
into their active forms. On the basis of this precedent, it was proposed that the 
cellular uptake of MOE analogues would be improved by the addition of acetyl esters 
to the hydroxyl groups of sugars. So, peracetylation of sugars is an extremely good 
solution to improve the uptake by the cells19. 
 
 
1.2.4. Monitoring Surface and Metabolic Flux Responses to MOE Analogues 
 
1.2.4.1. Measurement of Surface Display of Non-Natural Sugar Residues 
 
The methods used to evaluate the degree of replacement of natural sugars by 
the corresponding non-natural residues are very important tools in order to evaluate 
their display on the cell surface. 
Surface changes upon analogue incorporation can be detected, in some cases, 
using lectins20, and in other times, by the use of antibodies that can be generated and 
used, at least in theory, as imaging agents21. Neither lectins nor antibodies have yet 
proved to be highly quantitative and reproducible for probing modified glycan display, 
but they remain valuable because they can provide conclusive qualitative evidence for 
metabolic incorporation of an analogue. 
Radiolabeled probes constituted an early strategy to quantify analogue 
incorporation into cellular glycans and follow incorporation into membrane fractions7a. 
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Rigorous determination of analogue incorporation into glycans, however, required 
isolation of the carbohydrate-containing components by methods not compatible with 
physiological conditions such as acid hydrolysis followed by chromatographic 
analysis22. Similarly, separation methods including thin layer chromatography that 
have been employed for detection of sialic acids found in gangliosides cannot be 
performed on living cells23. Consequently, the tandem development of analogues with 
orthogonal chemistries not naturally found in the glycocalyx, including ketones8b, 
azides24, and thiols25 along with complementary chemoselective ligation strategies 
compatible with physiological conditions have greatly facilitated the detection and 
quantification of surface displayed non-natural sugars.  
 
 
1.2.4.2. Measurement of Intracellular Flux and Metabolite Levels 
 
Several factors have motivated the development of methods to quantify 
intracellular metabolites to complement measurements of surface display of non-
natural sugars. First, in cases when the detection of modified sugars on the cell 
surface is difficult, the monitoring of intracellular flux provides a rough measure of 
metabolic utilization of the precursor analogue. For example, it is relatively 
straightforward to measure the production of sugar intermediates by colorimetric 
assays, especially for the sialic acid pathway where the periodate-resorcinol assay has 
been widely applied26. Consequently, the metabolic uptake and pathway incorporation 
of analogues that support a large increase in flux can be monitored easily by such 
colorimetric assays27. By contrast certain analogues that lead to surface modifications 
do not measurably change intracellular metabolite levels. In these cases the flux of 
non-natural intermediates through the pathway is real but quantitatively small 
compared to endogenous metabolites and simple colorimetric assays are not 
informative. In these situations, although requiring significantly more effort, detailed 
analytical characterization of intracellular metabolites or media components, to test 
pathway interception or membrane transit, respectively, is possible by 
chromatographic methods28 or by using radioactive tracers27b. 
In conclusion, monitoring intracellular metabolic intermediates serves the dual 
purposes of verifying intake into the targeted glycosylation pathway as well as 
identifying ‘bottlenecks’ that hinder efficient metabolic processing. 
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1.3. Glycosylation Pathways and Analogues Used in MOE 
 
1.3.1. Overview of Sialic Acid Biosynthesis and Biological Function 
 
The sialic acid biosynthetic pathway, which consists of enzymes, transporters, 
and metabolites (figure 1.5), was exploited to pioneer both the basic concept of MOE7a 
as well the subsequent development of the cell surface chemoselective ligation 
technology8b, 29. Besides, sialic acids have been suggested to play roles in human 
evolution both far in the past by affecting the brain development30 and more recently 
through persistently changing patterns of Siglec recognition31. 
 
 
 
Figure 1.5 – The sialic acid biosynthetic pathway including four options for intercepting this 
pathway with MOE analogues. 
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Sialic acids are attractive candidates for MOE for several reasons. In first hand, 
these sugars normally appear as terminal residues situated at the non-reducing ends 
of oligosaccharides. So, they are present in the outer periphery of the glycocalyx and 
they are ideally positioned to interact with other cells, signalling molecules, 
pathogens, or exogenously supplied chemoselective ligation reagents. 
The sialic acid biosynthetic pathway is also very attractive for MOE because it is 
unusually permissive to substrate alterations, perhaps because Nature already 
exploits sialic acid biosynthesis with a type of MOE where over 50 different naturally 
occurring structural variations are introduced into this sugar32. 
 
 
1.3.2. Introduction of Orthogonal Chemical Functional Groups into ManNAc 
Analogues 
 
The first analogues of N-acetyl-D-mannosamine (ManNAc) used in MOE 
displayed simply alkyl chain extensions, branched chains and ring structures, and 
chemical functional groups already common in sugars. While these compounds were 
valuable for diverse purposes ranging from cancer immunotargeting10b, 21a to altering 
receptor-binding interactions20, 33, the efforts of the Bertozzi group to exploit metabolic 
processes to incorporate orthogonal, reactive functionality into cell-surface 
glycoproteins added an important new dimension to MOE.  
One of the most innovative experiments was the derivatization of a 
mannosamine analogue with a levulinoyl side chain (N-Levulinoyl-D-mannosamine 
(ManNLev), figure 1.6). The key feature of ManNLev was the presence of the ketone 
group in the N-acyl levulinoyl (“lev”) moiety that is foreign to the cell surface and will 
readily undergo selective reaction with chemoselective ligation agents such as 
aminooxy, hydrazide, or related functional groups to form covalent adducts. After the 
synthesis of ManNLev, several additional ketone-derivatized ManNAc analogues have 
been reported. 
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Figure 1.6 – Chemical structure of N-Levulinoyl-D-mannosamine. 
 
 
In the continuing expansion of MOE, additional ManNac analogues containing 
orthogonal functional groups for glycocalix display include thiol groups and the azide 
group of N-azidoacetyl-D-mannosamine (ManNAz) (figure 1.7) and the peracetylated 
counterpart 1,3,4,6-tetra-O-acetyl-N-azidoacetyl-α,β-D-mannosamine (Ac4ManNAz) 
(figure 1.7). The display of azides is particularly attractive from a chemical standpoint 
because unlike ketones (that exist inside a cell) or thiols (that occur ubiquitously in a 
cell with the exception of the glycocalyx) these groups are completely abiotic and can 
be exploited for orthogonal reactions intracellularly, on the cell surface, or even in the 
extracellular matrix. To recap, the display of ketones, azides, or thiols is 
fundamentally different than alkyl chains or hydroxyl groups. While the latter groups 
have the remarkable ability to influence sialic acid-specific biological activities, the 
analogues containing functional groups not naturally present in sugars install new 
chemical reactivity onto the cell surface. 
 
 
 
Figure 1.7 – Left: chemical structure of ManNAz; Right: chemical structure of Ac4ManNAz. 
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1.3.3. ManNAc vs. Sialic Acid Analogues 
 
Sialic acid analogues are efficiently taken up by cells and generally offer 
superior flux compared to the corresponding ManNAc analogues (although in some 
cases, such as the azido derivatives, rates of metabolic processing are similar). 
Despite the apparent superiority of sialic acid analogues, a perusal of the literature 
reveals that the ManNAc analogues have been used more often in MOE experiments. 
One answer for this apparent disparity between theory and practice is the ready 
availability and facile chemical synthesis of ManNAc analogues compared to the 
relatively difficult de novo chemical synthesis of the corresponding sialic acids. 
 
The synthesis of sialic acid is laborious, requiring normally more than 16-steps, 
so, not surprisingly, the difficulty of purely synthetic approaches spurred efforts to 
obtain sialic acid analogues by neuraminic acid (Neu5Ac) aldolase-catalysed 
condensation of pyruvate and the corresponding ManNAc analogue34. 
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2. Results and Discussion 
 
In this project three analogues of ManNAc were synthesized and tested as 
substrates of the enzyme sialic acid aldolase from Escherichia coli, which has been 
used as a model of the sialic acid synthase that is present in eukaryotic cells. The 
results of these assays would provide information about the efficacy of these 
analogues to be processed by the enzyme, and would help on choosing the best 
analogue to be used in MOE. One of these analogues is being tested for eventual 
fluorine radiolabeling, which consists in a major advantage for imaging (diagnosis) 
and possibly treatment. 
 
 
2.1. Synthesis of ManNAc Derivatives 
 
Three different ManNAc derivatives, bearing an azide (ManNAz), a ketone 
(ManNLev) and a thiol (ManNSH) group were synthesized, since these variations are 
commonly used in MOE.  
 
 
2.1.1. Synthesis of ManNAz 
 
For the synthesis of N-azidoacetyl-D-mannosamine (ManNAz), we have used a 
precursor previously prepared, the azidoacetic acid. This compound was obtained by 
reaction between sodium azide and bromoacetic acid in water (figure 2.1)35. 
 
 
 
Figure 2.1 - Schematic synthesis of azidoacetic acid 
 
 
The structural characterization of the product was performed by 1H-NMR, 13C-
NMR and IR analysis. 
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The synthesis of N-azidoacetyl-D-mannosamine (ManNAz) was carried out by 
two different experimental approaches, as depicted in figure 2.2. 
 
Figure 2.2 – Two different approaches for the synthesis of N-azidoacteyl-D-mannosamine. 
 
For both synthesis it is used a coupling reagent, 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDC) in the first approach and N,N'-
Dicyclohexylcarbodiimide (DCC) in the second approach. These two reagents are used 
for the coupling of primary amines to yield amide bonds and act similarly, helping the 
reaction between D-mannosamine and azidoacetic acid. However, the second 
approach (route 2, figure 2.2) uses a carboxylic acid activator reagent, N-
hydroxysuccinimide (NHS), and gives higher yield of product. 
 
 
2.1.2. Synthesis of ManNLev 
 
The synthesis of N-Levulinoyl-D-mannosamine (ManNLev) was achieved by 
reaction between D-mannosamine and levulinic acid in the presence of isobutyl 
chloroformate (figure 2.3). The isobutyl chloroformate is a coupling reagent that 
promotes the reaction by forming an anhydride with the levulinic acid36. 
Figure 2.3 – Schematic synthesis of N-Levulinoyl-D-mannosamine. 
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2.1.3. Synthesis of ManNSH 
 
The synthesis of N-thioacetyl-D-mannosamine (ManNSH) involves three steps. 
The synthetic approach used in these three steps is present in the next scheme (figure 
2.4).  
 
 
Figure 2.4 – Schematic synthesis of N-thioacetyl-D-mannosamine. 
 
In the first step, the 2-mercaptoacetic acid reacts with triphenylmethanol to 
obtain the corresponding 2-S-protected acetic acid 19. Then, compound 19 is reacted 
with D-mannosamine, in presence of EDC and NHS, to obtain the D-mannosamine 
with the desired protecting group (21). Finally, compound 21 is hydrolysed with a 
solution of trifluoroacetic acid (TFA), triisopropylsilane (TIS) and water in a 95:2.5:2.5 
ratio to obtain N-thioacetyl-D-mannosamine (22). 
 
The structural characterization of all ManNAc analogues was performed by 1H 
NMR, 13C NMR, and Mass spectrometry. These compounds are easily identified in 1H 
NMR spectra due to the several characteristic peaks of mannosamine. 
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2.2. Kinetic Results for ManNAc and its Derivatives 
 
2.2.1. Optimization of the Enzymatic Reaction Conditions  
 
In order to evaluate the potentiality of the three ManNAc analogues that were 
synthetized (ManNAz, ManNLev and ManNSH) for being used in MOE, some enzymatic 
assays were carried out to see their behaviour towards the sialic acid aldolase. This 
study may allow to predict, approximately, what is the rate of conversion of these 
analogues inside the cell on the sialic acid pathway and which will eventually be 
expressed in the glycocalix. 
This study was carried out using High Performance Liquid Chromatography 
(HPLC) as analytical tool. For that, several conditions were optimized, namely the type 
and size of the column to be used, the appropriate mobile phase, the flow rate, and 
the wavelength of the detector. The best column to be used with this type of 
compounds is an amine column, which is normally used for carbohydrates, organic 
acids and bases, and small molecules analysis. It was concluded that the best mobile 
phase to use with these compounds is an isocratic mobile phase constituted by a 
mixture of acetonitrile and sodium phosphate buffer (20mM, pH=5.6) in a 1:1 ratio. 
The wavelength set for these experiments was 215 nm. 
To perform the enzymatic reactions, it was also necessary to optimized certain 
parameters, namely the reaction time, the temperature, and finally but not less 
important the quantities of each component to be used, especially of the enzyme to 
obtain good results on an appropriate time of reaction. All the conditions were easy to 
establish, except the quantity of enzyme to use due to the different activity of 
different batches of enzyme. The enzymatic reaction that takes place is shown in the 
following figure and the amounts used for each component are presented in table 2.1. 
 
Figure 2.5 – Schematic synthesis of the sialic acid derivatives. 
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Table 2.1 – Conditions used in the enzymatic reaction. 
ManNAc 
Derivatives 
(75mM) 
Tris-HCl 
Buffer pH=7.5 
(400mM) 
MgCl2 
(150mM) 
Sodium 
Pyruvate 
(200mM) 
H2O 
Sialic Acid 
Aldolase K-12 
from E. coli 
Total 
Volume 
5µL 
(7.5mM) 
12.5µL 
(100mM) 
6.7µL 
(20mM) 
10µL 
(40mM) 
12.8µL 
3µL 
(30mU) 
50µL 
 
 
 
As a buffer it was used tris-HCl buffer to compensate those variations. It was 
chosen due to its advantages, namely the fact that this buffer is inexpensive, very 
freely soluble in water, inert in many enzymatic systems and has a Shigh buffer 
capacity (pH=7.5 to 9.0). It is used an MgCl2 solution, because Mg2+ stabilizes the 
nucleophile (pyruvate anion) in the active site37. 
 
Mechanistically, the sialic acid aldolase catalyses the aldolic addition of ManNAc 
and derivatives and sodium pyruvate. This aldolase removes the α proton of the 
carbonyl group of pyruvate, thus generating a carbon nucleophile bond at the active 
site. This catalysis is extremely efficient and stereospecific37. 
 
More specifically, sialic acid aldolase catalyses the reversible aldol reaction of N-
acetyl-D-mannosamine (ManNAc) and pyruvate to form N-acetylneuraminic acid (sialic 
acid). This enzyme forms a Schiff base/enamine intermediate with pyruvate and thus, 
promoting of a 4S stereocenter for the natural substrate (ManNAc). The first step of 
the reaction is the ring-opening of the α-anomer of sialic acid affording the open form, 
which in turn forms a shiff base between the C2 carbonyl group and a lysine in the 
active site. Further interconversion Schiff base/enamine produces the retro-aldol 
reaction, releasing pyruvate and N-acetylmannosamine (which undergo ring-closure 
spontaneously). For synthetic purposes, the equilibrium of the pyruvate dependent 
aldolases is shifted toward the products through the use of excess pyruvate38. 
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2.2.2. Calibration curves for substrates and product 
 
Before performing the analysis of the enzymatic reactions in HPLC, it was 
necessary to obtain the calibration curves for substrates, reagents and products. For 
that purpose, solutions of different molarity of ManNAc and its derivatives, sodium 
pyruvate and sialic acid were prepared and injected in the HPLC column. All analyses 
were performed using a normal phase Kromasil-NH2 (5 µm, 4.6 x 250 mm) column 
and an isocratic mobile phase made with a mixture of acetonitrile and sodium 
phosphate buffer (20mM, pH=5.6) in a 1:1 ratio. The wavelength set for these 
experiments was 215 nm. 
 
 
2.2.2.1 Calibration curve of ManNAc 
 
For ManNAc’s calibration five solutions of different molarity (0.5, 1, 2.5, 5 and 
10mM) were prepared and injected in the HPLC column. The chromatograms obtained 
are present in figure 2.6. Under the analytical conditions indicated above, the 
retention time (RT) for ManNAc is around 3.9 minutes. 
 
 
Figure 2.6 – Chromatogram of ManNAc at different concentrations. 
 
Then, it is possible to establish a correlation between the peaks’ area and the 
concentration of ManNAc (figure 2.7). 
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Figure 2.7 – Lineal regression curve for the concentration of ManNAc versus area. 
 
To get the best correlation possible, statistical analysis (standard deviation, F-
test, etc.) was performed. It was concluded that the best correlation is obtained 
excluding the value obtained for 5mM ( ) (equation 2.1). 
 
2.2.2.2 Calibration curve of ManNAz 
 
For ManNAz’s calibration five solutions of different molarity (0.5, 1, 2.5, 5 and 
10mM) were prepared and injected in the HPLC column. The chromatograms obtained 
are present in figure 2.8. The retention time (RT) for ManNAz is around 3.5 minutes. 
 
 
Figure 2.8 - Chromatogram of ManNAz at different concentrations. 
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With the peaks’ area it is possible to establish a correlation between them and 
the concentration of ManNAz (figure 2.9). 
 
Figure 2.9 - Lineal regression curve for the concentration of ManNAz versus area. 
 
After statistical analysis, the best correlation found for ManNAz is                 
 ( ) (equation 2.2) and contains all values of 
concentration 
 
2.2.2.3 Calibration curve of ManNLev 
 
For ManNLev’s calibration five solutions of different molarity (0.5, 1, 2.5, 5 and 
10mM) were prepared and injected in the HPLC column. The chromatograms obtained 
are present in figure 2.10. The retention time (RT) for ManNLev is around 3.6 
minutes. 
 
 
Figure 2.10 - Chromatogram of ManNLev at different concentrations. 
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Then, it is possible to establish a correlation between the peaks’ area and the 
concentration of ManNLev (figure 2.11). 
 
Figure 2.11 - Lineal regression curve for the concentration of ManNLev versus area. 
 
To get the best correlation possible, statistical analysis (standard deviation, F-
test, etc.) was performed. It was concluded that the best correlation is obtained 
excluding the value obtained for 2.5mM ( ) (equation 
2.3). 
 
2.2.2.4 Calibration curve of ManNSH 
 
For ManNSH’s calibration six solutions of different molarity (0.25, 0.5, 1, 2.5, 5 
and 10mM) were prepared and injected in the HPLC column. The chromatograms 
obtained are present in figure 2.12. The retention time (RT) for ManNSH is around 3.6 
minutes. 
 
 
Figure 2.12 - Chromatogram of ManNSH at different concentrations 
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With the peaks’ area it is possible to establish a correlation between them and 
the concentration of ManNSH (figure 2.13). 
 
Figure 2.13 - Lineal regression curve for the concentration of ManNSH versus area. 
 
After statistical analysis, the best correlation found for ManNSH is                 
 ( ) (equation 2.4), which was obtained excluding the 
value obtained for 5mM. 
 
2.2.2.5 Calibration curve of Pyruvate 
 
For pyruvate’s calibration five solutions of different molarity (0.5, 1, 2.5, 5 and 
10mM) were prepared and injected in the HPLC column. The chromatograms obtained 
are present in figure 2.14. The retention time (RT) for pyruvate is around 4.65 
minutes. 
 
 
Figure 2.14 - Chromatogram of pyruvate at different concentrations 
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With the peaks’ area it is possible to establish a correlation between them and 
the concentration of pyruvate (figure 2.15). 
 
Figure 2.15 - Lineal regression curve for the concentration of pyruvate versus area. 
 
After statistical analysis, the best correlation found for pyruvate is                 
 ( ) (equation 2.5), which was obtained excluding the 
value obtained for 5mM. 
 
2.2.2.6 Calibration curve of Sialic Acid 
 
For sialic acid’s calibration five solutions of different molarity (0.5, 1, 2.5, 5 and 
10mM) were prepared and injected in the HPLC column. The chromatograms obtained 
are present in figure 2.16. The retention time (RT) for sialic acid is around 7.2 
minutes. 
 
 
Figure 2.16 - Chromatogram of sialic acid at different concentrations 
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With the peaks’ area it is possible to establish a correlation between them and 
the concentration of sialic acid (figure 2.17). 
 
Figure 2.17 - Lineal regression curve for the concentration of sialic acid versus area. 
 
After statistical analysis, the best correlation found for sialic acid is               
 ( ) (equation 2.6), which was obtained excluding the 
value of 5mM. 
 
The correlations found for each reaction component were used to determine its 
concentration in the enzymatic reaction. 
 
 
2.2.3. Determination of initial reaction rates of ManNAc and its Derivatives 
 
The initial reaction rate for each ManNAc derivative was determined, and 
compared with that of the enzyme’s natural substrate (ManNAc). 
 
 
2.2.3.1. Determination of initial reaction rate for ManNAc 
 
To determine the initial reaction rate for ManNAc, an enzymatic reaction using 
this substrate with the conditions shown in table 2.1 was set. The reaction was 
performed in ten different eppendorfs that represent different times of the reaction, 
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which were subsequently analysed by HPLC. The mixture was incubated at 37ºC in a 
shaker at 150 rpm. For ManNAc and its derivatives independent duplicates were 
performed to obtain more accurate results. 
 
The peak area values of the product, sialic acid, obtained for each reaction time 
were converted to concentration values applying the equation 2.6 and then to number 
of moles. This was done in duplicate and the average number of moles was plotted 
versus time (see the graphic below). In few cases were obtained values that were 
clearly out of the graphic, and these were not considered. 
 
 
Figure 2.18 – Reaction time vs. Number of moles of sialic acid formed. 
 
The slope of the initial part of the graphic gives the initial rate of sialic acid 
formation, which is 0.0027µmol/min. 
 
 
2.2.3.2. Determination of initial reaction rate for ManNAz 
 
The procedure to determine the initial reaction rate of ManNAz was similar to 
that described for ManNAc. In this case the equation used to convert the peak’s area 
into concentration was equation 2.2. In the HPLC chromatogram the peak 
corresponding to sialic acid containing the azide group appears at 6.1-6.2 minutes. 
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Figure 2.19 – HPLC overlapped chromatograms showing the peak of sialic acid containing the 
azide group at different reaction times.  
 
 
 
Figure 2.20 - Reaction time vs. Number of moles of sialic acid containing the azide group 
formed. 
 
 
The initial rate of the formation of sialic acid containing the azide group 
obtained was 0.0013µmol/min. 
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2.2.3.3. Determination of initial reaction rate for ManNLev 
 
The procedure to determine the initial reaction rate of ManNlev was similar to 
that described for ManNAc. In this case the equation used to convert the peak’s area 
into concentration was equation 2.3. The peak correspondent to sialic acid containing 
the levulinic group is around 6.4-6.5 minutes. 
 
 
Figure 2.21 - HPLC overlapped chromatograms showing the peak of sialic acid containing the 
levulinic group at different reaction times. 
 
 
Figure 2.22 - Reaction time vs. Number of moles of sialic acid containing the levulinic group 
formed. 
The initial reaction rate of the formation of sialic acid containing the azide group 
obtained was 0.0008µmol/min. 
 
6,96,856,86,756,76,656,66,556,56,456,46,356,36,256,26,156,16,056
35
30
25
20
15
10
5
0
-5
-10
-15 RT [min]
ER3xManLev_0'27.DATA
ER3xManLev_100'27.DATA
ER3xManLev_120'27.DATA
ER3xManLev_140'27.DATA
ER3xManLev_160'27.DATA
ER3xManLev_180'27.DATA
ER3xManLev_20'27.DATA
ER3xManLev_210'27.DATA
ER3xManLev_240'27.DATA
ER3xManLev_40'27.DATA
ER3xManLev_60'27.DATA
ER3xManLev_80'27.DATA
mA
y = 0,0008x + 0,001
R² = 0,989
0
0,02
0,04
0,06
0,08
0,1
0,12
0,14
0 100 200 300
n 
(µ
m
ol
)
t (min.)
You created this PDF from an application that is not licensed to print to novaPDF printer (http://www.novapdf.com)
Chapter 2 – Results and Discussion 
 
32 
Master’s Thesis of Inês Rodrigues 
2.2.3.4. Determination of initial reaction rate for ManNSH 
 
The procedure to determine the initial reaction rate of ManNSH was similar to 
that described for ManNAc. In this case the equation used to convert the peak’s area 
into concentration was equation 2.4.  
 
 
 
Figure 2.23 - HPLC overlapped chromatograms showing the peak of sialic acid containing the 
thiol group at different reaction times. 
 
 
The enzymatic assays for the ManNSH derivative were problematic, probably 
due to the oxidation of thiol group. As it can be seen in figure 2.23, the peak 
appearing in the region assigned to the sialic acid derivative varies between 6 and 11 
minutes and the value obtained for the peaks’ area are not consistent. Attempts to 
perform the enzymatic reaction using a reducing agent, 2-mercaptoethanol, were 
unsuccessful. To represent the curve several points were excluded, however the 
results are tentative and unreliable (figure 2.24). 
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Figure 2.24 - Reaction time vs. Number of moles of sialic acid containing the thiol group 
formed. 
The value of the initial reaction rate of the formation of sialic acid containing the 
thiol group was obtained by doing the average of the two slopes of the two lines 
present in the graphic of figure 2.24. So the initial reaction rate of the formation of 
sialic acid containing the thiol group obtained was 0.00075µmol/min. 
 
 
2.2.3.5. Comparison of the results obtained for ManNAc and derivatives 
 
The initial reaction rates determined for the different mannosamine derivatives 
and their relative values with respect to the natural substrate ManNAC are shown in 
table 2.2. As it can be seen, the three ManNAc analogues were substrate of the 
enzyme although exhibited lower reaction rates than ManNAc, which is indicating that 
the enzyme is sensitive to the modifications performed on the substrate. 
Nevertheless, all the reaction rate values are in the same order of magnitude than 
that of the natural substrate ManNAc. Therefore, the three ManNAc analogues are 
good candidates for using in MOE.  
It is worth noting that the reaction rate with the azide derivative was higher 
than that of the bulkier Lev derivative, suggesting that the enzymatic reaction is 
affected by the size of the functional group. Although the value for the substrate with 
the small thiol group was even lower than that of the Lev derivative, the results with 
the thiol derivative may be underestimated due to the problems for determining the 
kinetics as mentioned above. 
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Table 2.2 - Comparison of the initial reaction rates of ManNAc and derivatives. 
 
 
 
 
2.3. Acetylation of ManNAc derivatives 
 
The three mannosamine derivatives that were synthesized (ManNAz, ManNLev 
and ManNSH) were peracetylated using conventional conditions with Ac2O/Py (see 
figure 2.25). As mentioned in the Introduction section, peracetylation would give 
precursors with improved membranes permeability since the acetyl groups increase 
the lipophilicity of the polar sugar derivatives. Besides, peracetylation allows an easier 
purification and gives products with higher stability (and better to store). After 
acetylation and subsequent purification the following peracetylated compounds were 
obtained: 1,3,4,6-tetra-O-acetyl-N-azidoacetyl-α,β-D-mannosamine (17), 1,3,4,6-
tetra-O-acetyl-N-levulinoyl-α,β-D-mannosamine (23) and 1,3,4,6-tetra-O-acetyl-N-
mercaptoacetyl-α,β-D-mannosamine (24) (Ac4ManNAz, Ac4ManNLev and Ac4ManNSAc, 
respectively). 
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Figure 2.25 - Acetylation of ManNAc derivatives. 
 
For all peracetylated compounds was preformed 1H-NMR, 13C-NMR, and Mass 
spectrometry analysis. In the 1H-NMR spectrum of these three compounds it is 
possible to observe the characteristic peaks of acetyl groups that appears around 
2ppm, which indicates that the ManNAc derivatives were successfully peracetylated. 
 
 
2.4. Derivatization of Ac4ManNAz 
 
After completion of the kinetic studies with the ManNAc analogues, ManNAz was 
found to be the un-natural ManNAc analogue with better metabolic conversion into the 
respective sialic acid derivative. For this reason, this analogue was chosen for further 
experiments in order to test the viability of an alternative method that could quantify 
its in vivo cellular metabolic processing and incorporation onto the cell surface. After 
incorporation in the glycocalix, the azide group (bioorthogonal chemical reporter) of 
sialic acid is expected to react with a terminal alkyne via formation of a triazole group. 
We have hypothesised that using a radiolabeled-based alkyne would allow the 
quantification of the triazole group formation and therefore provide information about 
the number of sialic acid units on the surface cell (figure 2.26). Taking into 
consideration that fluorine-18 (18F) is an isoster of hydrogen, this radionuclide was 
chosen as the radioactive label. 18F is a positron-emitting isotope, widely utilized in 
the clinic for PET imaging. It has several advantages, namely its low positron energy 
(0.64 MeV) and optimal physical half-life of 110 min, which allows multistep 
radiosynthesis39. 
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Figure 2.26 – Incorporation of ManNAz in the cellular membrane as correspondent sialic acid 
and posterior derivatization with a radiolabeled compound.  
 
Aiming to test this hypothesis, we have decided to start the synthetic 
experimental work with the Ac4ManNAz. To start, we have designed the formation of a 
triazole containing Ac4Mannosamine by reacting Ac4ManNAz with an adequate terminal 
alkyne. Then, the final purpose would be to perform the 18F-labeling of the triazole 
containing Ac4Mannosamine as a means to test the labelling procedures and the 
feasibility to label such derivatives. 
In order to characterize the 18F-triazole containing Ac4Mannosamine, the 
synthesis of the 19F-triazole counterpart has also to be carry out.  While 
characterization of the inactive (cold) compounds can be done by common analytical 
techniques (1H NMR, 13C NMR, MS), characterization of radioactive (hot) compounds is 
done by analytical HPLC comparison with its inactive congener.  
For the synthesis of fluorinated Ac4Mannosamine derivative (cold fluorine) two 
synthetic strategies were adopted (figure 2.27). First, it was envisaged to perform the 
synthesis of fluorinated Ac4Mannosamine derivative 30, from the respective O-tosylate 
precursor 29. The advantage of this strategy is based on the fact that precursor 29 
could be used for the preparation of both 19F- and 18F-based Ac4Mannosamine 
derivative. Also, the preparation of 30 from the reaction of 17 with the fluoro-based 
alkyne 27 presented an obstacle, which resides on the fact that compound 27 has an 
extremely low boiling point (24.6ºC at 760mmHg), and therefore difficult to prepare. 
For this reason reaction of 27 with 17 to yield desired fluorinated Ac4Mannosamine 
derivative 30 is not possible. With the purpose to prepare further precursor 29, base 
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promoted reaction of but-3-yn-1-ol (25) with p-toluenesulfonic chloride afforded the 
desired but-3-yn-1-tosyloxy(26) in almost quantitative yield ( = 91%). 
As the ultimate goal of this work would be the incubation of structural similar 
alkynes with cells, in order to promote their reaction with the azide-containing sialic 
acid derivative on the cellular surface, we tried the [3 + 2] cycloaddition copper-free. 
First attempt to react 26 with Ac4ManNAz (17) in DMF at 90ºC has failed. No 
improvement was observed with the increase of the reaction temperature to 110-
120ºC. Based on these failed attempts, it was decided to promote the cycloaddition 
reaction catalysed by Cu(I) in basic medium. Under these conditions, the [3 + 2] 
cycloaddition of the alkyne of 26 to the azide of 17 occurred smoothly, at room 
temperature. 
 
 
 
Figure 2.27 - Synthetic strategies applied for the derivatization of Ac4ManNAz derivative. 
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Having the precursor 29 prepared, the next step consisted in the nucleophilic 
substitution of the O-tosyl group in 29 by a fluorinating agent. Tetra-n-
butylammonium fluoride (TBAF) is considered one of the best sources of nucleophilic 
fluoride. Its reactivity is higher, when compared to other fluorinating agents such as 
KF or CsF. However, attempt to carry out this fluorination reaction has failed 
redundantly. After refluxing for a short reaction time (15 minutes) TLC analysis 
indicated the formation of a series of products with lower Rf than the starting material 
29. After purification by chromatography, 1H NMR spectrum showed a multiplicity of 
peaks indicating the presence of more than one species. Also, the singlets attributed 
to the acetyl groups were absent in the 1H NMR spectrum. At this stage, it was 
postulated that in addition to act as nucleophile, the excess of fluorine acts also as 
base, promoting the O-acetyl hydrolyses. To test this hypothesis, the collected 
products were reacted with acetic anhydride and pyridine, as a way to re-acetylate the 
mixture. In spite of these efforts, only a small amount of a re-protected carbohydrate 
compound could be recovered. In the 1H NMR spectrum of this recovered product, the 
doubled triplet signal typical of methylene group adjacent to fluorine atom was 
observed. Also, 19F NMR spectrum showed the presence of fluorine atom in the 
molecule. This disappointed outcome indicated that during the fluorination reaction, 
other side-reaction occurred in addition to the hydrolyses of the acetate groups. The 
unprotected hydroxyl groups, upon fluorine-promoted deprotonation, might also act 
as nucleophile leading to the formation of inter- and intra-molecular by-products. 
To overcome the problems encountered when synthesizing the fluorinated 
Ac4Mannosamine derivative 30 by substitution of the O-tosylate group with 
nucleophile fluoride, a second synthetic approach was envisaged. In this strategy, the 
[3 + 2] cycloaddition was performed with alkyne 25, affording cycloadduct 28 in 
moderate yield ( = 40%). This yield was slightly lower, when compared with the 
synthesis of 29, which has been 57%.  
Introduction of the fluoro atom is intended to be achieved directly from the 
hydroxyl group using diethylaminosulfur trifluoride (DAST). DAST is a fluorinating 
agent, which converts alcohols to the corresponding alkyl fluorides. This reaction is 
under progress. The characterization of the compounds present in figure 2.27 is 
described in experimental section. 
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3. Conclusions and Perspectives 
 
As mentioned before, metabolic oligosaccharide engineering (MOE) is a 
relatively recent technique in the field of glycobiology, in which monosaccharide 
analogues are used to incorporate non-natural sugars into the glycocalix of the 
cellular membrane. For the success of this strategy, the functional groups 
incorporated in the monosaccharide analogue must be accepted by the enzymes of 
the oligosaccharide biosynthetic machinery. Biological functions of the carbohydrates 
present in the cellular membrane, such as signalling, recognition and/ or binding, can 
therefore be modulate by the incorporation of those non-natural sugars in the 
glycocalix. 
Aiming to prepare non-natural sugar to be explored for metabolic 
oligosaccharide engineering, three ManNAc analogues (ManNAz, ManNLev and 
ManNSH) were successfully synthesized. Further, it was determined the reaction rate 
of these analogues into the respective sialic acid derivative by the sialic acid aldolase. 
This enzymatic reaction provided initial insights of the suitability of these analogues as 
candidates for MOE. 
The three ManNAc analogues proved to be substrates of the sialic acid aldolase. 
However, the reaction rates found for these analogues were lower than the conversion 
of the natural substrate of the enzyme (ManNAc). This data indicates that the enzyme 
is sensitive to the modifications performed in the substrate. The reaction rate with the 
analogue containing the azide group (ManNAz) showed a higher reaction rate than the 
other two ManNAc analogues, suggesting that the enzymatic reaction is affected by 
the size of the functional group. The reaction rate using the thiol analogue (ManNSH) 
was the lowest. However, the value found has to be taken carefully due to the low 
stability of thiol group in the experimental conditions used for the enzymatic studies. 
The potential sulphur oxidation of this analogue had difficult the realization of the 
kinetic studies, and therefore may explain the less satisfactory results. 
The respective peracetylated ManNAc analogues (Ac4ManNAz, Ac4ManNLev, and 
Ac4ManNSH) were also prepared successfully. Derivatization of the Ac4ManNAz 
resulted in a triazole containing Ac4Mannosamine derivative. This compound will be 
further fluorinated and radiofluorinated. 
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Perspectives 
The synthesis of the radiofluorinated Ac4Mannosamine will be performed 
shortly, according the conditions present in figure 3.1. 
 
 
Figure 3.1 – Synthetic route to synthesize radiofluorinated Ac4Mannosamine derivative 
 
Alternatively, the two other non-natural analogues, Ac4ManNLev (23) and 
Ac4ManNSAc (24), could be explored for further labelling with a fluorescent probe, as 
exemplified in Figures 3.2 and 3.3. In the case of 23, it is envisaged the formation of 
a Schiff’s base between the carbonyl group and a fluorophore containing an amine 
(Figure 3.2). 
 
Figure 3.2 - Synthetic route to synthesize a fluorescent based Ac4Mannosamine derivative. 
 
For the Ac4ManNSAc derivative, it could be attached to a gold nanoparticle 
labelled also with a fluorescent probe. 
 
Figure 3.3- Synthetic route to synthesize a gold nanoparticle labelled with a fluorescent probe 
on Ac4ManNSAc. 
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4. Experimental Section 
 
4.1. General experimental details 
 
All chemicals from commercial suppliers were of reagent grade or higher. 
Tetrahydrofuran (THF) was freshly distilled from the sodium benzophenone ketyl 
radical ion. Acetonitrile (MeCN), dichloromethane (CH2Cl2) and triethylamine (Et3N) 
were distilled from calcium hydride. Methanol (MeOH) and toluene were distilled from 
sodium. Ethyl acetate and hexane were recovered from distillation. Other solvents 
used in the experimental work were used as received. 
 
Reactions were monitored by using thin layer chromatography (TLC) plates pre-
coated with silica UV254 (60 F254 Merck silica gel, 0.2 mm). Visualization of the plates 
was carried out using UV light (254 or 365 nm), and/or iodine container, or a solution 
of 5% H2SO4 in EtOH, or a solution of 2% ninhydrin (2,2-Dihydroxyindane-1,3-dione) 
in EtOH, followed by heating. 
 
Compounds were purified by gravity column chromatography (GCC) and flash 
chromatography (FC). The first was performed by using open columns loaded with 
silica gel (Merck 70-230 mesh, 0.063-0.200mm) and the other one was performed 
using thick-walled columns, employing silica gel 60 (Merck 230-400 mesh, 0.040-
0.063 mm). 
 
HPLC analyses were performed on a Jasco Pu-2089 Plus with a Jasco UV-2075 
Plus detector, using normal phase column Kromasil-NH2 (5 µm, 4.6 x 250 mm) 
column. Compounds were eluted with an isocratic mobile phase (50% 
acetonitrile/50% sodium phosphate buffer (20mM, pH=5.6)). The wavelength set for 
these experiments was 215 nm. 
 
NMR spectra were recorded on a Bruker-300 spectrometer (300 MHz for 1H and 
75 MHz for 13C), on Unity-500 spectrometer (500 MHz for 1H and 125 MHz for 13C) or 
on a Varian Unity 300 NMR spectrometer (300 MHz for 1H, 75 MHz for 13C and 282 
MHz for 19F). Chemical shifts are reported in parts per million (ppm). 1H and 13C 
chemical shifts were referenced with the residual solvents resonances relative to 
tetramethylsilane. 19F chemical shifts were referenced externally to α,α’,α’’-
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trifluorotoluene (0.05% in C6D6; δ = -63.3). Infrared spectra were obtained on a 
Perkin-Elmer Spectrum One FT-IR spectrometer (240-4000 cm-1). Mass spectroscopy 
spectra were registered on a HP series 1100 MSD spectrometer. 
 
4.2. Synthesis of ManNAc derivatives 
 
4.2.1. Synthesis of N-levulinoyl-D-mannosamine (ManNLev) (15) 
 
 
To a solution of levulinic acid (0.3 mL, 2.78 mmol) 
in dry THF (10 mL) was added Et3N (0.4 mL, 2.6 mmol). 
The reaction mixture was stirred at room temperature 
under an argon atmosphere. After 30 min, 0.3 mL of 
isobutyl chloroformate (2.6 mmol) was added dropwise by syringe and the stirring 
was kept for more 3 h, during which a white solid precipitated off. This crude reaction 
(levulinic acid isobutyl carbonic anhydride) was used directly in the next step. To a 
solution of 500 mg of mannosamine hydrochloride (2.32 mmol) in H2O/THF (5:4) (9 
mL) was added Et3N (0.4 mL, 2.6 mmol). The reaction mixture was stirred at room 
temperature for 5 minutes, after which the crude solution of levulinic acid isobutyl 
carbonic anhydride was added dropwise. After 17 hours the solvent was concentrated 
under vacuum. The residue was submitted to flash chromatography (EtOAC/MeOH 
6:1) to afford 15 slightly contaminated with Et3N. Further repurification was 
performed with a C18 column, to afford 15 (483 mg, 75%) as white amorphous foam. 
 
1H NMR (500 MHz, D2O) δ 4.98 (d, J = 1.3 Hz, 1H), 4.90 (d, J = 1.5 Hz, 1H), 4.32 
(dd, J = 4.4, 1.3 Hz, 1H), 4.18 (dd, J = 4.7, 1.4 Hz, 1H), 3.91 (dd, J = 9.8, 4.7 Hz, 
1H), 3.78 (d, J = 2.2 Hz, 1H), 3.76 – 3.74 (m, 1H), 3.70 (d, J = 5.3 Hz, 1H), 3.69 – 
3.67 (m, 1H), 3.52 (t, J = 9.7 Hz, 1H), 3.41 (t, J = 9.8 Hz, 1H), 3.30 (ddd, J = 9.8, 
5.0, 2.2 Hz, 1H), 2.78 – 2.72 (m, 1H), 2.51 (t, J = 6.7 Hz, 1H), 2.45 (td, J = 6.6, 3.2 
Hz, 1H), 2.11 (s, 1H). 
 
13C NMR (125 MHz, D2O) δ 214.12, 213.91, 176.44, 175.66, 93.16, 93.04, 92.99, 
92.88, 76.29, 72.09, 71.99, 68.85, 68.74, 66.85, 66.76, 66.57, 66.51, 60.60, 60.48, 
60.45, 60.34, 54.04, 53.16, 53.10, 38.23, 38.16, 38.10, 29.37, 29.34, 29.29, 29.25, 
29.22. 
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4.2.2. Synthesis of ManNAz and precursors 
 
 
4.2.2.1. Synthesis of azidoacetic acid (18)  
 
To an ice-cooled solution of sodium azide (0.4688g, 
7.2mmol) in 4mL of water was added bromoacetic acid 
(0.5001g, 3.60mmol) and stirred for 5 hours. After this time, the 
reaction was acidified with HCl 1M for neutralization. The product 
was extracted with diethyl ether (4 x 25mL) from the aqueous solution. The organic 
layer was dried over Na2SO4 and was filtered. Concentration of the filtrate under 
vacuum afforded 18 (189 mg, 52%). 
 
IR (KBr) ν 3450.79, 2926.60, 2116.22, 1729.43, 1420.43, 1284.21, 1220.48 cm-1. 
 
1H NMR (300 MHz, D2O) δ 3.96 (1H, d, CH2). 
 
13C NMR (75 MHz, D2O) δ 173.00 (C=O), 50.49 (CH2). 
 
 
4.2.2.2. Synthesis of N-azidoacetyl-D-mannosamine (ManNAz) (16) 
 
Method A: 
 
To a stirred suspension of D-mannosamine 
hydrochloride (170.1 mg, 0.79 mmol) and 1-ethyl-3-(3-
dimethyllaminopropyl)carbodiimide (EDC, 301.1 mg, 1.57 
mmol) in dry DMF (12mL) was added a solution of azidoacetic 
acid (18,157.8 mg, 1.56 mmol) in dry DMF (3mL) at room 
temperature. After 10 minutes, the reaction mixture was cooled down to 0°C, followed 
by dropwise addition of Et3N (0.4 mL). The reaction mixture was stirred for more 24 
hours at room temperature. Thereafter, the reaction solvent was evaporated and the 
resulting residue was submitted to flash chromatography (CH2Cl2/MeOH 9:1 to 7:1) to 
give 16 (50 mg) as a colourless oil contaminated with Et3N.  
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Et3N was removed after resubmitting contaminated 16 to flash chromatography 
(EtOAc/MeOH 10:1 to 4:1), followed by a C18 column. After this laborious purification, 
compound 16 (16 mg, 7.7 %) was obtained as a white solid. 
 
Method B: 
The N-succinimidyl azidoacetate was prepared by reacting azidoacetic acid (18) 
(620mg, 6.73mmol) with N-hydroxysuccinimide (387 mg, 3.37 mmol) and DCC (695 
mg, 3.37 mmol) in 5 mL dry DMF for 1h at 5°C. This mixture was filtered before 
adding to the mannosamine hydrochloride salt. 
To a solution of mannosamine hydrochloride salt (723 mg, 3.37 mmol) 5 mL in 
dry DMF (5 mL) was added N-succinimidyl azidoacetate and a few drops of Et3N, 
under an argon atmosphere. The reaction mixture was stirred overnight (15 h). 
Thereafter, the solvent was evaporated and the residue was submitted to flash 
chromatography (CH2Cl2/MeOH 15:1 to 5:1) to give 16 (575 mg, 65%) as a white 
solid.  
1H NMR (300 MHz, CD3OD) δ 5.03 (d, J = 1.4 Hz, 1H), 4.43 (d, J = 2.9 Hz, 1H), 4.30 
(dd, J = 4.5, 1.4 Hz, 1H), 4.08 – 3.95 (m, 2H), 3.92 (d, J = 7.2 Hz, 1H), 3.84 – 3.73 
(m, 3H), 3.71 – 3.63 (m, 1H), 3.55 (t, J = 9.5 Hz, 1H), 3.42 (dd, J = 17.5, 7.8 Hz, 
1H), 3.34 – 3.28 (m, 1H). 
 
13C NMR (75 MHz, CD3OD) δ 169.06, 94.68, 73.59, 73.48, 70.49, 68.53, 62.24, 
55.23, 53.43, 52.65, 43.52, 43.33, 26.95, 15.67, 9.19. 
 
HRMS calcd for C8H14N4O6 (M+Na)+ 262.0911, found 262.0913. 
 
4.2.3. Synthesis of ManNSH and precursors 
 
4.2.3.1. Protection of 2-mercaptoacetic acid (19) 
To a solution of triphenylmethanol (4.92 g, 18.9mmol) in 
dry DMF (25 mL) was added 2-mercaptoacetic acid (1.2 mL, 
17.2mmol). The mixture was stirred for 30 min at 60°C. After 
this, the mixture was cooled down to room temperature followed 
by the addition of BF3.Et2O (2.4 mL, 18.9mmol). The stirring was 
kept for more 20 hours at 60°C. After removing the solvent 
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under vacuum, the product was purified by flash chromatography (hexane/EtOAc 
2:1). Compound 19 (5.63 g) was obtained as a white solid in quantitative yield. 
 
1H NMR (300 MHz, CD3OD) δ 7.40 – 7.29 (m, J = 4.5, 2.9 Hz, 3H), 7.28 – 7.09 (m, J 
= 10.8, 7.4, 4.4, 1.4 Hz, 5H), 2.95 (s, 1H). 
 
HRMS calcd for C21H20O2S (M-H)- 334.1028, found 334.1021. 
 
 
4.2.3.2. Synthesis of N-((2’-S-trityl)acetyl)-D-mannosamine (21) 
 
To a solution of protected 2-mercaptoacetic acid 19 
(1,0 g, 3 mmol) and N-hidroxysuccinimide (0.34 g, 3 mmol) 
in DMF was added EDC (0.4657, 3mmol) at 0°C. The 
reaction mixture was stirred for 1h. Then mannosamine 
hydrochloride and a few drops of Et3N were added. The mixture was stirred for more 
20 hours at room temperature. After the evaporation of the solvent under vacuum, 
the residue was submitted to flash chromatography (EtOAc/MeOH 100:0 to 5:1) to 
provide 21 (0.92 g, 62% ) 
 
1H NMR (300 MHz, CD3OD) δ 7.44 – 7.37 (m, 1H), 7.35 – 7.27 (m, 1H), 7.26 – 7.19 
(m, 1H), 4.95 (s, 1H), 4.85 (s, 1H), 4.63 (s, 1H), 4.34 (dd, J = 4.3, 1.5 Hz, 1H), 4.15 
(dd, J = 4.6, 1.6 Hz, 1H), 3.96 (dd, J = 9.7, 4.7 Hz, 1H), 3.82 – 3.77 (m, 1H), 3.75 
(dd, J = 3.9, 1.9 Hz, 1H), 3.72 (dd, J = 4.3, 2.2 Hz, 1H), 3.62 (dd, J = 9.5, 4.3 Hz, 
1H), 3.45 (t, J = 9.5 Hz, 1H), 3.41 – 3.34 (m, 1H), 3.21 (ddd, J = 9.7, 4.3, 2.6 Hz, 
1H). 
 
 
4.2.3.3. Synthesis of N-thioacetyl-D-mannosamine (ManNSH) (22) 
 
To a solution of glycoside 21 (0.92 g, 1.9 mmol) in 
CH2Cl2 (10mL) was added 20mL of a trifluoroacetic acid 
(TFA), triisopropylsilane (TIS) and water (95:2.5:2.5-V/V/V 
solution). The reaction was stirred at room temperature for 
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17h. The solvents were removed by vacuum. The residue was submitted to flash 
chromatography (CH2Cl2/MeOH 9:1 to 6:1) to provide 22 (0.20 g, 42%). 
 
1H NMR (300 MHz, CD3OD) δ 5.37 (dd, J = 9.3, 2.3 Hz, 1H), 4.37 (dd, J = 15.6, 7.8 
Hz, 1H), 4.23 (dd, J = 5.5, 2.9 Hz, 1H), 3.99 (ddd, J = 8.5, 5.7, 3.1 Hz, 1H), 3.79 
(dd, J = 11.6, 3.1 Hz, 2H), 3.70 – 3.64 (m, 2H), 3.61 (d, J = 5.8 Hz, 1H), 2.73 (dd, J 
= 14.9, 2.3 Hz, 1H). 
 
13C-NMR (75 MHz, CD3OD) δ 176.95, 81.53, 81.13, 72.46, 71.02, 65.46, 61.57, 
29.34. 
 
HRMS calcd for C8H15NO6S (M+Na)+(-H2O) 253.0620, found 253.0619. 
 
 
4.3. Acetylation of ManNAc derivatives 
 
 
4.3.1. Synthesis of 1,3,4,6-tetra-O-acetyl-N-azidoacetyl-α,β-D-mannosamine 
(Ac4ManNAz) (17) 
 
N-azidoacetyl-D-mannosamine (16) (564 mg, 
2.15 mmol) was left to react overnight at room 
temperature with 6mL of acetic anhydride and 6mL of 
pyridine. After that time, the solvents were evaporated 
and the product was purified by flash chromatography 
(n-hexane/EtOAc 2:1 to 1:1). Compound 17 (606 mg) was obtained in 71% as a 
white foam. 
 
1H NMR (300 MHz, CDCl3) δ 5.83 (d, J = 1.7 Hz, 1H), 5.30 – 5.19 (m, 1H), 5.18 – 
5.07 (m, 1H), 5.07 – 4.96 (m, 2H), 4.71 – 4.60 (m, 1H), 4.54 (ddd, J = 9.3, 4.2, 1.9 
Hz, 1H), 4.20 – 4.08 (m, 2H), 4.08 – 3.87 (m, 10H), 3.78 (ddd, J = 8.2, 7.1, 5.9 Hz, 
1H), 2.13 – 1.85 (m, 15H). 
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4.3.2. Synthesis of 1,3,4,6-tetra-O-acetyl-N-levulinoyl-α,β-D-mannosamine 
(Ac4ManNLev) (23) 
 
N-levulinoyl-D-mannosamine (15) (483 mg, 1.74 
mmol) was left to react overnight at room temperature 
with 5mL of acetic anhydride and 5mL of pyridine. 
Thereafter, the solvents were evaporated under 
vacuum and product was purified by flash chromatography (EtOAc/n-hexane 5:1). 
Compound 23 (290 mg) was obtained in 37 % as a white foam. 
 
1H NMR (300 MHz, CDCl3) δ 6.39 (dd, J = 45.0, 9.3 Hz, 1H), 6.01 – 5.77 (m, 1H), 
5.24 (dd, J = 10.1, 4.4 Hz, 1H), 5.18 – 4.98 (m, 1H), 4.71 (ddd, J = 9.3, 8.0, 2.5 Hz, 
1H), 4.55 (ddd, J = 17.4, 8.7, 6.9 Hz, 1H), 4.30 – 4.17 (m, 1H), 4.11 – 3.94 (m, 2H), 
3.83 – 3.70 (m, 1H), 2.80 – 2.69 (m, 2H), 2.62 – 2.30 (m, 2H), 2.04 (ddd, J = 34.1, 
22.1, 6.7 Hz, 15H). 
 
 
4.3.3. Synthesis of 1,3,4,6-tetra-O-acetyl-N-acetylthioacetamido-α,β-D-
mannosamine (Ac4ManNSAc) (24) 
 
N-thioacetyl-D-mannosamine (22) (200 mg, 0.79 
mmol) was left to react overnight at room temperature 
with 2mL of acetic anhydride and 2mL of pyridine. 
Thereafter the solvents were removed and the product 
was purified by flash chromatography (EtOAc). Compound 24 (50 mg) was obtained in 
14% as a white foam.  
 
1H NMR (300 MHz, CDCl3) δ 1H NMR (300 MHz, CD3OD) δ 5.46 (ddd, J = 9.1, 7.7, 2.7 
Hz, 1H), 5.36 – 5.17 (m, 1H), 5.10 (d, J = 1.7 Hz, 1H), 4.85 (s, 1H), 4.69 – 4.49 (m, 
1H), 4.24 – 4.03 (m, 1H), 3.98 – 3.85 (m, 1H), 3.44 (t, J = 12.7 Hz, 1H), 3.34 – 3.20 
(m, 1H), 2.85 (dt, J = 10.3, 5.2 Hz, 1H), 2.38 (ddd, J = 7.8, 6.4, 2.6 Hz, 1H), 2.15 – 
1.91 (m, 1H). 
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4.4. Preparation of Ac4Mannosamine derivatives 
 
4.4.1. Synthesis of but-3-ynyl-1-tosyloxy (26) 
 
 To a solution of but-3-yn-1-ol (25) (1.1 mL, 14.3 
mmol) in CH2Cl2 (50 mL) was added p-TsCl (4.1 g, 21.4 
mmol) and pyridine (2.5 mL, 31.5 mmol). The reaction was 
stirred at room temperature for 24 hours. Then, the solvent was removed under 
vacuum. The residue was taken in diethyl ether and was washed consecutively with 
water, 1 M HCl, sat. NaHCO3 and brine. The organic phase was dried over MgSO4, was 
filtered and the filtrate was concentrated. The reaction crude was submitted to column 
chromatographic on silica gel (EtOAc/petroleum ether 15:85) to afford 26 (2,89 g, 
91%). 
 
 
1H NMR (300 MHz, CDCl3) δ 7.81 (d, 2H), 7.36 (d, J = 8.0 Hz, 2H), 4.11 (t, J = 7.0 
Hz, 2H), 2.56 (td, J = 7.0, 2.7 Hz, 2H), 2.46 (s, 3H), 1.98 (t, J = 2.7 Hz, 1H). 
 
 
 
4.4.2. Synthesis of 1,3,4,6-tetra-O-acetyl-N-[4`-(2’’-tosyloxyethyl)-1’,2’,3’-
triazolyl)]acetyl-α,β-D-mannosamine (29) 
 
To a solution of 1,3,4,6-tetra-O-
acetyl-N-azidoacetyl-α,β-D-mannosamine 
(17) (234 mg, 0.54 mmol) in MeCN (6 mL) 
was added 26 (122 mg, 0.54 mmol), CuI 
(207 mg, 1.1 mmol) and DIPEA (0.3 mL, 1.6 mmol). The reaction mixture was stirred 
at room temperature for 4 hours. Then, water and ammonium chloride were added 
and the product was extracted with ethyl acetate (50 mL). The organic layer was 
washed with brine and then was dried over Na2SO4, filtered and the filtrate was and 
concentrated. The residue was submitted to column chromatographic on silica gel 
(EtOAc/petroleum ether 3:1) to give compound 29 (200 mg, 57 %). 
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1H NMR (300 MHz, CDCl3) δ 7.69 (d, J = 8.3 Hz, 2H), 7.59 (s, 1H), 7.37 – 7.26 (m, 
3H), 5.96 (d, J = 1.6 Hz, 1H), 5.83 (d, J = 1.8 Hz, 1H), 5.27 (dd, J = 10.1, 4.4 Hz, 
1H), 5.09 (d, J = 4.2 Hz, 1H), 5.05 – 4.99 (m, 1H), 4.72 (dd, J = 9.1, 1.3 Hz, 1H), 
4.59 (ddd, J = 9.1, 4.4, 1.7 Hz, 1H), 4.24 (t, J = 6.5 Hz, 2H), 4.10 – 4.02 (m, 3H), 
3.06 (t, J = 6.3 Hz, 2H), 2.38 (s, 3H), 2.12 (s, 2H), 2.07 – 1.96 (m, J = 10.3, 3.4 Hz, 
11H), 1.93 – 1.87 (m, 3H), 1.20 (t, J = 7.1 Hz, 3H). 
 
 
 
4.4.3. Synthesis of 1,3,4,6-tetra-O-acetyl-N-[4`-(2``-hydroxyethyl)-1’,2’,3’-
triazolyl)]acetyl-α,β-D-mannosamine (30) 
 
To a solution of 1,3,4,6-tetra-O-acetyl-
N-azidoacetyl-α,β-D-mannosamine (17) (200 
mg, 0.47 mmol) in MeCN (5 mL) was added 
25 (30 L, 0.47 mmol), CuI (207 mg, 1.1 
mmol) and DIPEA (0.24 mL, 1.4 mmol). The reaction mixture was stirred at room 
temperature for 4 hours. Then, water and ammonium chloride were added and the 
product was extracted with ethyl acetate (50 mL). The organic layer was washed with 
brine and then was dried over Na2SO4, filtered and the filtrate was and concentrated. 
The residue was submitted to column chromatographic on silica gel (EtOAc/MeOH 5:1) 
to give compound 30 (92 mg, 40 %). 
 
 
1H NMR (300 MHz, CDCl3): bad resolution – the peaks could not be identified, but it is 
possible to know if it is the compound, due to the presence of characteristic peaks, 
namely the proton on the triazole group. 
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4.5. Enzymatic assays preparation 
 
For the enzymatic assays several solutions had to be prepared. For ManNAc and 
its derivatives was prepared a solution of each one of 75mM. To prepare tris-HCl 
buffer 400mM, first was weighted tris (2-Amino-2-hydroxymethyl-propane-1,3-diol) 
and dissolved in distilled water and then tritated with hydrochloric acid until reach 
pH=7.5. It was also prepared a 150mM solution of magnesium chloride (MgCl2) and a 
200mM solution of sodium pyruvate. The enzyme batch of 10 units was diluted in 1mL 
of distilled water. To reach a total volume of 50µL of the enzymatic reaction it was 
added distilled water. The mobile phase of 1:1 phosphate buffer pH=5,6/Acetonitrile 
was prepared by weighing disodium phosphate and diluting with distilled water to 
reach a 20mM solution. Then the pH was adjusted to 5.6 and it was added the same 
volume of acetonitrile. 
 
 
4.6. Safety and ecological measures 
 
All operations were performed using a lab coat, eyeglasses and gloves (latex 
gloves for acetone, nitrile gloves for other solvents) and performed inside the fume 
hood. All reactants were stored in an explosion-resistant cabinet, fridge and normal 
cabinet according to the nature of the reactant. To manipulate silica-gel powder was 
always used a proper mask. 
 
Relatively to ecological measures, whenever possible EtOH was used instead of 
MeOH due to its toxicity, and some material, namely pipettes, were reutilized. 
Moreover, the different chemical waste produced within this project was separated in 
different containers to be treated properly. 
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5. Project Budget 
 
 Products Providers Quantity for unit Price per unit /€ 
Amount 
used 
Estimated 
price/€ 
S
ol
ve
n
ts
 
CH2Cl2 
Fisher 
Chemicals 2.5 L 11.20 2.000 L 8.96 
CHCl3 
Fisher 
Chemicals 2.5 L 13.24 0.030 L 0.16 
CDCl3 Merck 500 mL 79.00 12 mL 1.90 
n-hexane 
Fisher 
Chemicals 2.5 L 16.48 0.400 L 2.64 
Petroleum ether 
Fisher 
Chemicals 2.5 L 14.20 1.000 L 9.09 
THF 
Fisher 
Chemicals 2.5 L 22.80 0.200 L 1.82 
EtOAc Fisher Chemicals 2.5 L 22.80 6.000 L 54.72 
Acetone Fisher Chemicals 5 L 8.44 4.000 L 6.75 
EtOH Fisher Chemicals 2.5 L 12.32 0.020 L 0.10 
MeOH Sigma-Aldrich 2.5 L 7.00 2.000 L 5.60 
CD3OD Merck 25 mL 49.00 25.0 mL 49.00 
Diethylether Panreac 1 L 51.93 0.250 L 12.98 
Pyridine Panreac 1 L 61.77 0.026 L 1.61 
Et3N Scharlau 1 L 37.85 0.005 L 1.25 
CH3CN 
Fisher 
Chemicals 2.5 L 21.00 3.000 L 25.20 
DMF Fisher Chemicals 2.5 L 14.10 0.100 L 0.56 
Total cost of Solvents 182.34 
R
ea
g
en
ts
 
D-Mannosamine 
HCl 
Carbosynth 10 g 373.50 4.300 g 160.61 
SAA K-12 Sigma-Aldrich 1-10un 207.50 30u 622.50 
Sodium pyruvate Sigma-Aldrich 500g 407.50 5.000g 4.08 
tris Sigma-Aldrich 500g 63.00 5.000g 0.63 
MgCl2 Sigma-Aldrich 1Kg 49.00 1.000g 0.05 
NaN3 Sigma-Aldrich 25 g 106.50 5.000g 21.30 
TBAF Sigma-Aldrich 1M in THF 
(100mL) 
102.50 14 mL 14.35 
p-TsCl  99% Fluka 100 g 26.50 5.000 g 1.33 
DCC  99% Aldrich 25 g 14.10 1.000 g 0.56 
EDC  98% Sigma-Aldrich 25 g 259.50 3.000 g 31.14 
Bromoacetic acid Sigma-Aldrich 25 g 49.10 5.500 g 10.80 
NHS Sigma-Aldrich 100 g 83.20 0.360 g 0.30 
triphenylmethanol Sigma-Aldrich 50g 37.10 5.500 g 4.08 
Levulinic acid Sigma-Aldrich 50g 14.30 0.450 g 0.13 
Isobutyl 
chloroformate 
Sigma-Aldrich 25g 16.80 0.450g 0.30 
But-3-yn-1-ol Sigma-Aldrich 5g 36.50 1.300g 9.50 
CuI Sigma-Aldrich 50g 20.70 0.450g 0.19 
DIPEA Sigma-Aldrich 100mL 114.50 0.700mL 0.80 
Ac2O Sigma-Aldrich 1L 53.70 0.040L 2.15 
MgSO4 96% Panreac 1 Kg 19.00 2.000 g 0.22 
NaHCO3 98% Acrós Organics 1 Kg 15.33 2.000 g 0.08 
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Total cost of Reagents 885.10 
M
at
er
ia
ls
 
silica 230-400 
mesh Merck 5 kg 425.50 1.500 kg 130.00 
silica 70-230 mesh Merck 5 kg 322.00 0.300 kg 19.00 
TLC plates Merck 25 un/box 63.76 10un 30.00 
pasteur pipets Normax 250 un / box 5.46 210 un 4.59 
lab film Parafilm 3810 cm x 10 cm 19.80 150cm x 10cm 0.78 
Total cost of Materials 184.37 
S
er
vi
ce
s 
 
NMR 
 
 300 MHz 
Varian or 
Bruker  
1 /h or 5/night 90 22.50 
ESI-MS HP  8 /sample 8 64,00 
Total cost of Analytical Services 86.50 
TOTAL 1338.31 
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